SG Americas Securities LLC Invests $87,000 in Aemetis, Inc. (NASDAQ:AMTX)

SG Americas Securities LLC bought a new stake in Aemetis, Inc. (NASDAQ:AMTX) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 32,445 shares of the specialty chemicals company’s stock, valued at approximately $87,000. SG Americas Securities LLC owned about 0.07% of Aemetis at the end of the most recent reporting period.

Several other large investors have also recently bought and sold shares of the business. Clear Harbor Asset Management LLC purchased a new position in shares of Aemetis during the fourth quarter worth about $44,000. FMR LLC lifted its position in Aemetis by 68.2% in the third quarter. FMR LLC now owns 22,531 shares of the specialty chemicals company’s stock valued at $52,000 after purchasing an additional 9,137 shares during the period. Barclays PLC lifted its position in shares of Aemetis by 274.6% during the 3rd quarter. Barclays PLC now owns 47,496 shares of the specialty chemicals company’s stock valued at $109,000 after acquiring an additional 34,816 shares during the period. Wellington Management Group LLP acquired a new stake in shares of Aemetis during the 3rd quarter valued at approximately $177,000. Finally, State Street Corp lifted its position in shares of Aemetis by 36.1% during the 3rd quarter. State Street Corp now owns 699,089 shares of the specialty chemicals company’s stock valued at $1,608,000 after acquiring an additional 185,304 shares during the period. Hedge funds and other institutional investors own 27.02% of the company’s stock.

Aemetis Trading Up 0.5 %

NASDAQ:AMTX opened at $2.01 on Friday. The firm has a market capitalization of $102.81 million, a price-to-earnings ratio of -0.89 and a beta of 1.44. The firm’s fifty day simple moving average is $2.61 and its 200 day simple moving average is $2.80. Aemetis, Inc. has a twelve month low of $1.93 and a twelve month high of $7.03.

Aemetis (NASDAQ:AMTX) last issued its quarterly earnings data on Tuesday, November 12th. The specialty chemicals company reported ($0.38) EPS for the quarter, topping analysts’ consensus estimates of ($0.47) by $0.09. The firm had revenue of $81.44 million during the quarter, compared to analyst estimates of $77.79 million. During the same quarter in the prior year, the firm earned ($0.59) EPS. On average, analysts predict that Aemetis, Inc. will post -2.07 earnings per share for the current year.

Wall Street Analysts Forecast Growth

AMTX has been the subject of a number of recent research reports. HC Wainwright reissued a “buy” rating and set a $28.00 price objective on shares of Aemetis in a research note on Monday, December 23rd. StockNews.com raised shares of Aemetis to a “sell” rating in a research note on Wednesday, February 5th. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and four have issued a buy rating to the stock. According to MarketBeat.com, Aemetis has an average rating of “Moderate Buy” and a consensus price target of $12.95.

Aemetis Profile

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.